Professor Zhang Junping's Experience in Treating Chronic Heart Failure Based on Pathogenesis as Well as Prescription and Syndrome in Four Seasons

ZHANG Ao; QI Zhongwen; WANG Mingyang; SH IQi; FU Huanjie; ZHANG Junping

doi:10.16368/j.issn.1674-8999.2021.12.539

Suggestions

您当前的位置：

首页 >

文章列表页 >

Professor Zhang Junping's Experience in Treating Chronic Heart Failure Based on Pathogenesis as Well as Prescription and Syndrome in Four Seasons

Previous: Guo Weiqin's Experience in Treatment of Coronary Heart Disease with Sleep Disorder by Supplementing Qi, Activating Blood, and Soothing Nerves

Next: 无

Professor Zhang Junping's Experience in Treating Chronic Heart Failure Based on Pathogenesis as Well as Prescription and Syndrome in Four Seasons
1.The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin China 300381
DOI：10.16368/j.issn.1674-8999.2021.12.539

扫描看全文

ZHANG Ao, QI Zhongwen, WANG Mingyang, et al. Professor Zhang Junping's Experience in Treating Chronic Heart Failure Based on Pathogenesis as Well as Prescription and Syndrome in Four Seasons[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.16368/j.issn.1674-8999.2021.12.539
DOI：

ZHANG Ao, QI Zhongwen, WANG Mingyang, et al. Professor Zhang Junping's Experience in Treating Chronic Heart Failure Based on Pathogenesis as Well as Prescription and Syndrome in Four Seasons[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.16368/j.issn.1674-8999.2021.12.539 DOI：

摘要

治疗慢性心力衰竭以温通心阳、益气养血法为主，对于射血分数在50%以上，即射血分数保留患者，以育心通阳方为主方以调心养心、育心荣心；对于射血分数低于50%以下，兼有下肢水肿较重、活动受限、不能平卧、胃脘饱满等症状的患者，给予育心化水方以行气利水，温通心阳。同时慢性心力衰竭具有四时证候差异特点，结合四时气候特点及患者病情变化，形成四时辨治心力衰竭方案。遣药组方施以益心春、益心夏、益心秋、益心冬四时方药，取得良好临床疗效。

Abstract

The treatment of chronic heart failure (CHF) is mainly focus on warming the heart Yang and replenishing Qi and nourishing Blood. For patients with an ejection fraction above 50%, that is, the HFREF, the Yuxin Tongyang Recipe is the main prescription to adjust, tonifying, nourishing, and replenishing the heart. For patients with ejection fraction below 50%, severe lower extremity edema, limited mobility, inability to lie on their backs, full gastric cavity, etc., Yuxin Huashui Decoction is given to promoting Qi and diuresis, warming Heart, and activating Yang. At the same time, CHF has the characteristics of different syndromes in the four seasons, combined with the four seasons climate characteristics and changes in the patient's condition, the four seasons syndrome differentiation and treatment plan is formed. The four seasons prescriptions of tonifying Heart spring, tonifying Heart summer, tonifying Heart autumn, and tonifying Heart winter were applied to the prescription group, which achieved good clinical effects.

关键词

慢性心力衰竭病机证候四时方证张军平

Keywords

chronic heart failurepathogenesissyndromeprescription and syndrome in four seasonsZhang Junping

references

中国心力衰竭诊断与治疗质量评价和控制指标专家共识[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 52-62.

张杰, 梁美珍. 急性心肌梗死后心室重构的中医药干预作用机制研究进展[J]. 中医药导报, 2021, 27(8): 128-132, 137.

王丽蓉, 谢盈彧, 陈馨浓, 等. 基于“血-脉-心-神”一体观辨治射血分数保留性心力衰竭[J]. 中华中医药杂志, 2020, 35(8): 3957-3961.

谢盈彧, 方子寒, 李渊芳, 等. 国医大师阮士怡运用育心保脉理论辨治心力衰竭经验[J]. 中国中西医结合杂志, 2020, 40(11): 1388-1391.

马颖, 王博龙, 王亮, 等. UHPLC-Q-TOF-MS整合网络药理学研究升陷汤有效成分及其治疗慢性心力衰竭的作用机制[J]. 中国中药杂志, 2021, 46(10): 2489-2500.

方子寒, 谢盈彧, 王铭扬, 等. 益气活血方对慢性心力衰竭大鼠心室重构的干预作用及其机制[J]. 中国实验方剂学杂志, 2020, 26(4): 82-87.

毛鑫羽, 黄宇虹, 王保和. “有故无殒”理论对香加皮应用的启发[J]. 环球中医药, 2021, 14(2): 261-263.

杨虹, 刘虹, 任晓亮, 等. 香加皮抗心力衰竭有效部位的制备工艺研究[J]. 天津中医药大学学报, 2011, 30(3): 169-171.

张国顺, 白义萍, 王小兰, 等. 葶苈子抗心衰有效组分筛选及其作用机制分析[J]. 中国实验方剂学杂志, 2017, 23(4): 118-125.

王咏, 马度芳, 王成, 等. 基于心脏成纤维细胞microRNA-22/TGFβ-1信号通路研究红花-葶苈子对心肌纤维化的抑制作用[J]. 辽宁中医杂志, 2020, 47(12): 171-175, 240.

杨雪, 李梦雨, 颜昌钖, 等. 香加皮的化学成分与药理作用研究进展及质量标志物的预测分析[J]. 中国中药杂志, 2020, 45(12): 2772-2783.

杨久亮. 治疗心力衰竭的新型药物研究进展[J]. 医学理论与实践, 2021, 34(11): 1830-1832.

SAUER A J, COLE R, JENSEN B C, et al. Practical guidance on the use of sacubitril/valsartan for heart failure[J]. Heart Fail Rev, 2019, 24(2): 167-176.

高源, 李嫣红, 郑刚. 沙库巴曲缬沙坦治疗心力衰竭的研究进展[J]. 中西医结合心脑血管病杂志, 2021, 19(17): 2947-2951.

黄佳佳, 马永成, 王爱凤. 348例心力衰竭患者沙库巴曲缬沙坦钠的临床应用的安全性评价和有效性分析[J]. 中国医院药学杂志, 2021, 41(6): 616-622.

郝佳梦, 王丹东, 集川原, 等. 射血分数保留型心力衰竭发病机制及治疗进展[J]. 世界中医药, 2021, 16(11): 1679-1684.

陈晨, 刘梅, 罗敏, 等. 从心力衰竭治疗理念变化看血管紧张素受体脑啡肽酶抑制剂研究进展[J]. 中南药学, 2021, 19(8): 1670-1675.

王红, 娄奇, 李为民. 沙库巴曲缬沙坦在射血分数保留心力衰竭患者中的临床研究进展[J]. 中国临床新医学, 2021, 14(6): 545-548.

吴晓博, 李军, 陈恒文, 等. 经方桂枝汤及其类方治疗心力衰竭的研究进展[J]. 中华中医药学刊, 2021, 39(3): 1-8.

卫靖靖, 郑超楠, 乔利杰, 等. 基于网络药理学探讨参附汤治疗慢性心力衰竭的作用机制[J]. 中药药理与临床, 2020, 36(4): 88-93.

王艳芬, 于晓红. 生脉饮治疗慢性心力衰竭疗效观察[J]. 陕西中医, 2014, 35(8): 982-984.

乔利杰, 彭广操, 卫靖靖, 等. 基于文献研究分析冠心病心力衰竭气虚血瘀证的用药规律[J]. 中国实验方剂学杂志, 2021, 27(9): 176-183.

宋玉, 王丽丽. 芪苈强心胶囊联合参附注射液在冠心病心力衰竭患者中的效果观察[J]. 贵州医药, 2020, 44(11): 1724-1725.

江华, 门鹏, 李潇潇, 等. 生脉注射液治疗慢性心力衰竭有效性及安全性的循证评价[J]. 临床药物治疗杂志, 2020, 18(11): 31-34.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of simple childhood obesity based on "Yang transforming Qi and Yinforming"

TCM Master Duan Ya-ting's Experience of Treating Chronic Heart Failure with Formula for Warming Kidney and Activating Blood Circulation

Example of Professor WENG Weiliang experience of treatment of chronic heart failure after myocardial infarction

Discussion on the Main Pathogenesis and Treatment Principle of Insomnia from Shaoyin Disease in Treatise on Febrile Diseases

Examples of Professor LI Ji's Proven Cases of Using Fructus Chaenomelis and Radix Paeoniae for Cramp

Related Author

No data

Related Institution

The Third Affiliated Hospital of Beijing University of Chinese Medicine

Chongqing Traditional Chinese Medicine Hospital

Xiyuan Hospital, China Academy of Chinese Medical Sciences

Dongzhimen Hospital, Beijing University of Chinese Medicine

Liaoning University of Traditional Chinese Medicine

⁰